Funding and support
EURAP is an independent research initiative promoted and implemented by physicians working on a non-profit basis. It is administratively organised by the Central Project Commission (CPC) with members representing different geographical areas and disciplines.
The project was established and carried out under the auspices of the European Epilepsy Academy (EUREPA) and it is endorsed by the Commission on Therapeutic Strategies of the International League Against Epilepsy (ILAE).
EURAP has been supported by educational grants to the CPC from Eisai Pharmaceuticals, GlaxoSmithKline, Janssen-Cilag, Johnson & Johnson, Pfizer, Bial, Sanofi-Synthelabo, Novartis, UCB Pharma, and Ratiopharm. In addition, national and regional networks may receive support from the same or other pharmaceutical companies.